StockData

National Healthcare Properties vs Sabra Health Care REIT

NHP and SBRA side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How NHP and SBRA compare

Sabra Health Care REIT is the larger company, worth 4.6 times as much as National Healthcare Properties ($5.0B against $1.1B).

Sabra Health Care REIT grew revenue faster over the last twelve months (17.3% versus −1.2% for National Healthcare Properties).

Both pay dividends: National Healthcare Properties yields 0.99% and Sabra Health Care REIT 6.1%.

Sabra Health Care REIT scores higher on the StockData Score (7 against 4 for National Healthcare Properties), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricNHPSBRA
Size and price
Market cap$1.1B$5.0B
Share price$15.08$19.74
Change, 1 year–14.6%
Change, 5 years–32.2%
Beta (5Y)–0.48
Employees3158
StockData Score
Total score47 (better)
Valuation score2 (better)0
Growth score12 (better)
Performance score02 (better)
Health score00
Dividend score13 (better)
Valuation
P/E–75.9×
P/S3.2× (better)5.9×
P/B1.0× (better)1.8×
EV/EBITDA10.4× (better)12.5×
Fair value$15.73$12.68
Margin of safety4.2% (better)−55.7%
Growth
Revenue growth (TTM)−1.2%17.3% (better)
Revenue growth, 5Y average−2.2%5.3% (better)
Net income growth (TTM)–−64.1%
EPS growth (TTM)–−65.8%
EPS growth, 5Y average–−0.91%
Profitability
Gross margin37.9%–
Operating margin3.2%–
Net margin–7.6%
Return on equity–2.4%
Return on invested capital1.3%–
Financial health
Interest coverage0.2×–
Altman Z-score0.911.25 (better)
Piotroski F-score–6
Dividends and buybacks
Dividend yield0.99%6.1% (better)
Payout ratio–455%
Years of dividend growth–0
Dividend growth, 5Y average–−2.3%
Shareholder yield0.99%6.1% (better)
Ownership
Held by institutions72.9%102%
Held by insiders0.35%1.9%
Insider net buying, 12 months–−$4.5M
Short interest, % of float4.6%7.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.